FDA lifts hold on Concert Pharma's study testing hair loss drug

(Reuters) - Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration (FDA) lifted a clinical hold on a trial testing its therapy for alopecia areata, a type of hair loss.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news